Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients

被引：0
|
作者：
O. Markovitch
R. Tepper
A. Fishman
R. Aviram
I. Cohen
机构：
[1] Meir Medical Center,Department of Obstetrics and Gynecology
[2] Sackler Faculty of Medicine,Gynecological Ultrasound Unit
[3] Tel Aviv University,undefined
[4] Meir Medical Center,undefined
来源：
Breast Cancer Research and Treatment | 2007年 / 101卷
关键词：
Endometrial thickness; Aromatase inhibitors; Tamoxifen; Ultrasound;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：185 / 190
页数：5
相关论文
共 50 条
  • [41] Tamoxifen or aromatase inhibitors in breast cancer : Efficacy and safety
    Neven, P.
    Van den Broecke, R.
    [J]. ACTA CHIRURGICA BELGICA, 2007, 107 (03) : 240 - 256
  • [42] The Effect of Exercise on the Alleviation of Side Effects Induced by Aromatase Inhibitors in Postmenopausal Breast Cancer Patients
    Zacharias Raptopoulos
    Constantina Constantinou
    [J]. Current Oncology Reports, 2020, 22
  • [43] Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
    Bertelsen, Bjorn-Erik
    Viste, Kristin
    Helland, Thomas
    Hagland, Magnus
    Soiland, Havard
    Geisler, Jurgen
    Lende, Tone Hoel
    Lonning, Per Eystein
    Sagen, Jorn, V
    Mellgren, Gunnar
    Almas, Bjorg
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (05): : 1368 - 1374
  • [44] The Effect of Exercise on the Alleviation of Side Effects Induced by Aromatase Inhibitors in Postmenopausal Breast Cancer Patients
    Raptopoulos, Zacharias
    Constantinou, Constantina
    [J]. CURRENT ONCOLOGY REPORTS, 2020, 22 (11)
  • [45] Effect of aromatase inhibitors on the lipid profile of postmenopausal breast cancer patients
    Markopoulos, Christos J.
    Tsaroucha, Alexandra K.
    Gogas, Helen J.
    [J]. CLINICAL LIPIDOLOGY, 2010, 5 (02) : 245 - 254
  • [46] TAMOXIFEN-ASSOCIATED ENDOMETRIAL CARCINOMA IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
    MALFETANO, JH
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 39 (01) : 82 - 84
  • [47] Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients
    Cohen, I
    Bernheim, J
    Azaria, R
    Tepper, R
    Sharony, R
    Beyth, Y
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 75 (01) : 136 - 141
  • [48] Response to "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by L.!Morales et al. (Ann Oncol 2005; 16: 70-74)
    Cohen, I
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (08) : 1402 - 1402
  • [49] Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors
    Engmann, Natalie J.
    Scott, Christopher G.
    Jensen, Matthew R.
    Ma, Lin
    Brandt, Kathleen R.
    Mahmoudzadeh, Amir Pasha
    Malkov, Serghei
    Whaley, Dana H.
    Hruska, Carrie B.
    Wu, Fang Fang
    Winham, Stacey J.
    Miglioretti, Diana L.
    Norman, Aaron D.
    Heine, John J.
    Shepherd, John
    Shane Pankratz, V.
    Vachon, Celine M.
    Kerlikowske, Karla
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (06) : 930 - 937
  • [50] Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
    Dackus, Gwen M. H. E.
    Jozwiak, Katarzyna
    Sonke, Gabe S.
    van der Wall, Elsken
    van Diest, Paul J.
    Siesling, Sabine
    Hauptmann, Michael
    Linn, Sabine C.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (11) : 1506 - 1514
12345